Related Experiment Videos
Comparative studies on rabbit corpus cavernosal contraction and relaxation. An in vitro study
R M Levin1, J Hypolite, G A Broderick
1Division of Urology, University of Pennsylvania School of Medicine, Philadelphia.
Journal of Andrology
|January 1, 1994
Summary
Nitric oxide (NO) is the primary mediator of erectile function relaxation. Inhibiting NO synthesis with L-NAME significantly reduced relaxation, while other pathways had minimal impact, highlighting NO
Area of Science:
- Urology
- Physiology
- Pharmacology
Background:
- Erectile function relies on complex neuronal and humoral factors.
- Nitric oxide (NO) is a key modulator of smooth muscle relaxation in erectile tissue.
Purpose of the Study:
- To quantify the roles of nitric oxide, adrenergic, purinergic, and cholinergic pathways in erectile function.
- To elucidate the specific mechanisms of smooth muscle relaxation during erection.
Main Methods:
- Field stimulation of corporal smooth muscle.
- Pharmacological inhibition using L-NAME (NO synthase inhibitor), atropine, propranolol, and methylene blue (guanylyl cyclase inhibitor).
- Assessment of relaxant responses to various stimuli including ATP and nitroprusside.
Main Results:
- L-NAME inhibited over 95% of field-stimulated relaxation, indicating NO's dominant role.
- Adrenergic and cholinergic blockers had no significant effect on relaxation.
- Methylene blue was less effective in inhibiting field-stimulated relaxation compared to bethanechol-stimulated relaxation.
Conclusions:
- Nitric oxide is the principal mediator of neurogenic relaxation in erectile tissue.
- Other neurotransmitter systems play a minor role in this specific relaxant response.
- Pharmacological agents like ATP and nitroprusside can induce relaxation comparable to field stimulation.